MedPath

The change of urine L-FABP for patients with SGLT2 inhibitor with type 2 diabetes

Phase 4
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000047695
Lead Sponsor
Sapporo Diabetes and Thyroid Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
124
Inclusion Criteria

Not provided

Exclusion Criteria

1.those who had serious liver or kidney diseases. 2.those who was with diabetic ketosis, coma, or pre-coma. 3.those who had infection, peri-operation, operation, or trauma. 4.those who was with pregnancy 5.those who was judged inappropriate as participants.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath